Walleye Trading’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175K Sell
99,483
-92
-0.1% -$200 ﹤0.01% 3194
2025
Q4
$234K Buy
99,575
+52,498
+112% +$143K ﹤0.01% 3312
2025
Q3
$144K Buy
+47,077
New +$134K ﹤0.01% 3542
2022
Q2
Sell
-8,232
Closed -$29K 5179
2022
Q1
$29K Buy
+8,232
New +$23.9K ﹤0.01% 4663
2021
Q4
Sell
-7,268
Closed -$54K 5407
2021
Q3
$54K Sell
7,268
-19,232
-73% -$165K ﹤0.01% 4613
2021
Q2
$353K Buy
+26,500
New +$260K ﹤0.01% 3325
2020
Q4
Sell
-49,643
Closed -$619K 4634
2020
Q3
$619K Sell
49,643
-149,147
-75% -$1.65M ﹤0.01% 2050
2020
Q2
$2.22M Buy
+198,790
New +$2.14M 0.01% 1016

Other funds holding CLOV

Walleye Trading's CLOV Position: Q1 2026 in Review

Walleye Trading reduced its Clover Health Investments (CLOV) stake by 0.09% in Q1 2026, selling an estimated $200 and leaving 99,483 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Walleye Trading first reported a position in CLOV in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.22M in Q2 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Walleye Trading held 99,483 shares of Clover Health Investments worth $175K as of Q1 2026.
  • Walleye Trading sold 92 Clover Health Investments shares in Q1 2026, an estimated $200.
  • Clover Health Investments made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3194 holding.
  • Walleye Trading first reported a position in Clover Health Investments in Q2 2020 and has held it in 8 quarters since.
  • Walleye Trading's Clover Health Investments position peaked at $2.22M in Q2 2020.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.